Literature DB >> 23723571

A spontaneous epithelial-myoepithelial carcinoma of the submandibular gland in a sprague-dawley rat.

Yinghua Li1, Hak-Soo Kim, Min-Soo Kang, Seo-Ho Shin, Kyo-Hwan Koo, Chul-Min Kim, Kap-Ho Kim, Charles Peck, Han-Ik Bae, Ji Yun Jeong, Jin Seok Kang, Boo-Hyon Kang.   

Abstract

The present report describes a rare case of spontaneous tumor of the salivary gland in a male Sprague-Dawley rat. The clinically confirmed mass rapidly developed in the cervical region between 19 and 21 weeks of age, and the animal was subsequently euthanized. At necropsy, a well-circumscribed nodule approximately 7 × 6 cm in diameter was found at the site of the salivary gland. The cut surface of the nodule was lobulated and soft and had a pinkish tan fish-flesh appearance. One large cyst (approximately 3 × 2 cm in size) containing reddish fluid was also present in the nodule. Histopathologically, the tumor, with a partially lobulated structure, was surrounded by a thin fibrous capsule. The majority of tumor cells formed a diffuse solid sheet structure that mainly consisted of small ovoid or spindle-shaped cells. In the tumor periphery, some cells were arranged in nest-like structures. Small duct-like structures lined with a monolayer of cuboidal epithelial cells resembling an intercalated duct or large polygonal clear cells with a myoepithelial component were also observed. Mitotic figures and necrotic foci were frequently observed in solid areas. Immunohistochemically, the tumor cells were positive for cytokeratin, epithelial membrane antigen, vimentin, p63, α-smooth muscle actin and calponin. The cells were negative for calcitonin, synaptophysin and chromogranin A. On the basis of these findings, the tumor was diagnosed as an epithelial-myoepithelial carcinoma originating from the luminal epithelial cells and myoepithelial cells in the submandibular gland.

Entities:  

Keywords:  Sprague-Dawley rat; epithelial-myoepithelial carcinoma; immunohistochemical features; submandibular gland

Year:  2013        PMID: 23723571      PMCID: PMC3620217          DOI: 10.1293/tox.26.67

Source DB:  PubMed          Journal:  J Toxicol Pathol        ISSN: 0914-9198            Impact factor:   1.628


Spontaneous tumors of the salivary glands in rats are very rare[1], [2], and most of them are diagnosed as adenomas or adenocarcinomas originating from acinar cells or a ductal epithelium[3]. Several detailed reports have analyzed salivary gland tumors in rats, epithelial neoplasms in Wistar rats[4], [5], adenocarcinomas in a rnu/rnu nude rats[6], pleomorphic adenomas and poorly differentiated carcinomas in Sprague-Dawley (SD) rats[7],[8],[9] and papillary cystadenocarcinomas in Fischer 344 rats[10]. However, only a few cases of epithelial-myoepithelial carcinoma (EMC), which is morphologically characterized by the proliferation of tumor cells consisting of epithelial and myoepithelial components, have been reported in humans[11],[12],[13]. In comparison with humans, the histogenetic classification of salivary gland tumors in rodents is very simple[14]. To date, the term EMC has not been used for the classification of a rodent salivary gland tumor. This report describes detailed morphological and immunohistochemical (IHC) characteristics of a rodent EMC. The animal was a male specific pathogen-free (SPF) SD rat (Hsd: Sprague Dawley® SD®) purchased from Koatech Inc., Republic of Korea. It was used as a vehicle control animal in a 13-week repeated-dose toxicity study and was submitted for sacrifice at the end of the study. The animal was housed in a solid bottom polycarbonate cage under routine controlled conditions (temperature, 23 ± 3°C; humidity, 55% ± 15%; lighting, 12 hours) and had free access to Teklad-certified, irradiated, global 18% protein rodent diet 2918C (Harlan Laboratories, Inc., USA) and sterilized tap water. At the end of the study, the animal was euthanized by exsanguination via the abdominal artery under isoflurane (Ifran liquid, Hana Pharm. Co., Ltd., Republic of Korea) anesthesia. The procedure for animal care was approved by the Institutional Animal Care and Use of Committees (IACUC) of Chemon Co., Ltd. based on the Animal Protection Act. The mass was clinically confirmed to have rapidly developed in the cervical region from 19 weeks of age until 21 weeks of age, when the animal was terminally sacrificed. At necropsy, a well-circumscribed nodule approximately 7 × 6 cm in diameter was found in the cervical region, in which normal submandibular, sublingual and parotid glands were not identified. The cut surface of the nodule was lobulated and soft and had a pinkish tan fish-flesh appearance. One large cyst (approximately 3 × 2 cm in size) containing reddish fluid was also present in the nodule (Fig. 1). However, the animal showed no abnormalities with regard to body weight, hematology or blood chemistry. The mass and other organs (including submandibular gland, sublingual gland, parotid gland and submandibular lymph node) were fixed in 10% neutral-buffered formalin, embedded in paraffin, cut into 4-μm thick sections, stained with hematoxylin and eosin (H&E) and examined microscopically. Additionally, IHC studies were performed on the tumor sections using a biotin-avidin peroxidase complex method and an automated immunostainer (BenchMark®; Ventana Medical Systems, Inc., Tucson, AZ, USA). The antibodies used in this study are described in Table 1. An indirect biotin-streptavidin system (iView DAB Detection Kit; Ventana Medical Systems, Inc., Tucson, AZ, USA) was used as the secondary antibody. The tumor sections were counterstained with hematoxylin (Ventana Medical Systems, Inc., Tucson, AZ, USA) and then treated with Bluing Reagent (Ventana Medical Systems, Inc., Tucson, AZ, USA). The IHC staining was scored semiquantitatively as negative (–), positive for a limited number of cells (+) and intensely positive for numerous cells (++) according to the proportion of immunoreactive cells and the intensity of reactivity.
Fig. 1.

Gross appearance of the tumor in the cervical region. The tumor is well circumscribed and lobulated and soft and had a pinkish tan fish-flesh appearance on the cut surface. One large cyst is present in the nodule (asterisk). 1 scale = 1 cm.

Table 1.

Antibodies Used in IHC Staining of the Tumor and the Normal Part of the Salivary Gland

Gross appearance of the tumor in the cervical region. The tumor is well circumscribed and lobulated and soft and had a pinkish tan fish-flesh appearance on the cut surface. One large cyst is present in the nodule (asterisk). 1 scale = 1 cm. Microscopically, the tumor had a thin fibrous capsule, it compressed the surrounding tissue, and it had lobules separated by delicate connective tissue septa (Fig. 2A). Small nests of tumor cells were seen outside the capsule in some areas (Fig. 2B), and the tumor and residual submandibular gland were surrounded by a fibrous capsule (Fig. 2C). The majority of the tumor cells formed a diffuse solid sheet structure that mainly consisted of small ovoid or spindle-shaped cells, with a pale oval nucleus containing a few prominent nucleoli (Fig. 2C). Along the tumor periphery, some tumor cells were arranged as nest-like structures. In some areas, small duct-like structures lined with a monolayer of cuboidal epithelial cells (Fig. 2D) resembling an intercalated duct or large polygonal clear cells with a myoepithelial component were observed (Fig. 2E)[12]. This characteristic myoepithelial component has been previously described in a human salivary gland tumor[13]. Mitotic figures were frequently observed throughout the tumor, suggesting that it grew rapidly. Necrotic foci were observed in solid areas (Fig. 2F). Cell debris and slight infiltration of neutrophils were present throughout the tumor (Fig. 2D). Slight infiltration of lymphocytes was seen in the thin connective tissue (Fig. 2B). Cribriform patterns, keratinization and arrangement of palisading cells were not found in the tumor. Microscopic examination revealed that there were no significant changes in other organs, especially in the submandibular lymph nodes, sublingual and parotid glands.
Fig. 2.

H&E staining of the tumor and normal part of the salivary glands. A: The tumor is lobulated, with the lobules separated by thin connective tissue, and the tumor compressed the surrounding tissue. The parotid gland can be seen in the upper right corner. Scale bar = 500 µm. B: Nests of tumor cells are seen outside the capsule. Lymphocytic infiltration is recognized in the thin connective tissue (arrow). Scale bar = 100 µm. C: On the left, the fibrous capsule surrounds the residual submandibular gland and tumor. In the middle, the normal part of the submandibular gland is adjacent to the tumor. The tumor consisted of a diffuse solid growth of small ovoid to spindle-shaped cells. Scale bar = 100 µm. D: Small duct-like structures lined with a monolayer of cuboidal epithelial cells. Cell debris and infiltration of neutrophils are observed. Scale bar = 25 µm. E: Large polygonal clear cells are observed in some areas. Scale bar = 50 µm. F: Necrotic foci are observed in solid growth areas (asterisks). Scale bar = 100 µm.

H&E staining of the tumor and normal part of the salivary glands. A: The tumor is lobulated, with the lobules separated by thin connective tissue, and the tumor compressed the surrounding tissue. The parotid gland can be seen in the upper right corner. Scale bar = 500 µm. B: Nests of tumor cells are seen outside the capsule. Lymphocytic infiltration is recognized in the thin connective tissue (arrow). Scale bar = 100 µm. C: On the left, the fibrous capsule surrounds the residual submandibular gland and tumor. In the middle, the normal part of the submandibular gland is adjacent to the tumor. The tumor consisted of a diffuse solid growth of small ovoid to spindle-shaped cells. Scale bar = 100 µm. D: Small duct-like structures lined with a monolayer of cuboidal epithelial cells. Cell debris and infiltration of neutrophils are observed. Scale bar = 25 µm. E: Large polygonal clear cells are observed in some areas. Scale bar = 50 µm. F: Necrotic foci are observed in solid growth areas (asterisks). Scale bar = 100 µm. The results of IHC analysis for the tumor and normal part of the submandibular gland are summarized in Table 2. In the normal tissue of the salivary gland, the membranes and cytoplasm of ductal luminal epithelial cells showed a positive reaction for cytokeratin (CK AE1/AE3) (Fig. 3A), and the cytoplasm was also positive for epithelial membrane antigen (EMA). The myoepithelial cells just beneath the luminal epithelial cells showed a positive reaction for calponin, α-smooth muscle actin (αSMA) and vimentin in the cytoplasm and for p63 in the nuclei.
Table 2.

Results of IHC Staining for Comparison Between the Tumor and the Normal Part of the Salivary Gland

Fig. 3.

IHC staining of the tumor and normal part of the submandibular gland. A: The tumor and duct epithelial cells in the normal part (arrows) show diffuse positive membraneous and cytoplasmic staining for CK AE1/AE3. Scale bar = 25 µm. B: The tumor cells show diffuse positive cytoplasmic staining for EMA. Scale bar = 25 µm. C: The tumor cells show positive cytoplasmic staining for vimentin. Scale bar = 25 µm. D: The tumor cells show positive nuclei staining for p63 but no p63 positivity in duct-like structures (arrows). Scale bar = 25 µm.

IHC staining of the tumor and normal part of the submandibular gland. A: The tumor and duct epithelial cells in the normal part (arrows) show diffuse positive membraneous and cytoplasmic staining for CK AE1/AE3. Scale bar = 25 µm. B: The tumor cells show diffuse positive cytoplasmic staining for EMA. Scale bar = 25 µm. C: The tumor cells show positive cytoplasmic staining for vimentin. Scale bar = 25 µm. D: The tumor cells show positive nuclei staining for p63 but no p63 positivity in duct-like structures (arrows). Scale bar = 25 µm. The duct-like structure of the epithelial component and the oval or spindle-shaped cells in the tumor showed a diffuse positive reaction for CK AE1/AE3 (Fig. 3A) in the membrane and cytoplasm and for EMA (Fig. 3B) in the cytoplasm. The large polygonal clear cells of the myoepithelial component and the oval or spindle-shaped cells in the tumor showed a positive reaction for vimentin (Fig. 3C), calponin and αSMA in the cytoplasm and for p63 (Fig. 3D) in the nuclei. However, the tumor cells were negative for calcitonin, synaptophysin and chromogranin A. On the basis of the histological appearance, the tumor diagnosis was consistent with EMC, which was further confirmed by the IHC investigation. An EMC is an extremely rare tumor, and only a few cases of EMC have been reported in the human salivary gland[12], [13]. However, the term EMC has not been used for the classification of salivary gland tumors in rodents. Histogenetic classification is hampered by the difficulty in determining the origin of a specific cell type in salivary gland tumors. Because the identification of myoepithelial cells, which constitute the basal layer of normal salivary gland epithelia, may be difficult in routinely stained sections, several IHC markers have been used to demonstrate the presence of epithelial cells and myoepithelial cells in order to determine their role in the histogenesis of salivary gland tumors. Diagnosis by IHC analysis involves various criteria, and studies have commonly reported positivity for epithelial markers including cytokeratin and EMA[15]. Calponin and αSMA have also been reported to be sensitive markers of myoepithelial differentiation in salivary glands[16], [17]. Therefore, to ensure sensitivity of detection, a panel of specific epithelial markers (CK AE1/AE3 and EMA), specific myoepithelial markers (calponin and αSMA) and nonspecific myoepithelial markers (vimentin and p63) were used in this study[18]. In the present tumor, CK AE1/AE3 and EMA were expressed in the epithelial component, whereas vimentin, calponin, αSMA and p63 were expressed in the myoepithelial component. The morphological and IHC characteristics of the epithelial and myoepithelial components in the present case were identical to those of the intercalated duct epithelial cells and myoepithelial cells in the normal part of the submandibular gland, respectively (Table 2). In addition, the histological features of this tumor were similar to those of EMC of the salivary gland in humans[12], [13]. Therefore, these characteristics strongly suggest that the tumor originated from both the luminal epithelial and myoepithelial cells of the intercalated duct in the submandibular gland. Furthermore, the oval or spindle-shaped tumor cells were positive for epithelial and myoepithelial markers (Table 2), suggesting that these tumor cells had differentiated into epithelial and myoepithelial cells. Therefore, the characteristic of tumor cell differentiation was correlated with the high-grade malignant nature in the present tumor. For differential diagnosis, mammary gland tumor, thyroid gland tumor and neuroendocrine origin tumor, all of which occur in a similar anatomical location, were considered. Mammary gland tumors mainly consist of glandular (ducts, ductules or alveoli) and fibrous connective components. In the present case, there were no histological findings suggestive of mammary gland tumors. A tumor of thyroid gland origin would be positive for calcitonin, a specific thyroid tissue marker, and a tumor of neuroendocrine origin would be positive for specific neuroendocrine tissue markers such as synaptophysin or chromogranin A[19], [20]. However, the tumor cells in our case were negative for calcitonin, synaptophysin and chromogranin A. Furthermore, the differential diagnosis could include other salivary gland tumors such as pleomorphic adenoma, adenoid cystic carcinoma and basal cell adenoma/carcinoma. Because this tumor did not show a clear mucoid stromal component (found in pleomorphic adenomas), a cribriform pattern (found in adenoid cystic carcinomas) or a distinct basement membrane-like structure and a characteristic nuclear palisading appearance at the periphery (found in basal cell adenoma/carcinomas), it could not be classified as any of the above salivary gland tumor types. In the salivary gland, criteria that have been reported to be helpful in differentiating between benign and malignant tumors include cytological atypia, mitotic activity and tumor infiltration into the surrounding salivary gland or other normal tissues[14]. In this case, rapid tumor growth, a fish-flesh sarcomatoid gross appearance, a diffuse solid growth pattern, the lack of any clear acinar structure or little tubular structure, prominent mitotic figures, necrotic foci and a tumor infiltrative margin, features associated with malignant behavior, were microscopically observed. In conclusion, on the basis of morphological and IHC characteristics, the tumor was diagnosed as a rare spontaneous EMC in the submandibular gland. To the best of the authors’ knowledge, there are very few reports on spontaneous epithelial tumors of the salivary gland, especially EMC. Given the nature of EMC, which has biphasic features with a variable combination and concentration of each components and a wide range of variations in histomorphology, more research to compile and further characterize EMC in rats is warranted. We hope that this data will aid in the classification of this uncommon tumor in rats in the future.
  16 in total

1.  Pathologic and immunohistochemical findings in a feline aortic body tumor.

Authors:  S Paltrinieri; P Riccaboni; M Rondena; C Giudice
Journal:  Vet Pathol       Date:  2004-03       Impact factor: 2.221

2.  Poorly differentiated carcinoma of the parotid gland in a six-week-old Sprague-Dawley rat.

Authors:  I Tsunenari; J Yamate; S Sakuma
Journal:  Toxicol Pathol       Date:  1997 Mar-Apr       Impact factor: 1.902

3.  Myoepithelial cell markers in salivary gland neoplasms.

Authors:  Cristiane Furuse; Suzana O Machado de Sousa; Fábio Daumas Nunes; Marina Helena Cury Gallottini de Magalhães; Vera Cavalcanti de Araújo
Journal:  Int J Surg Pathol       Date:  2005-01       Impact factor: 1.271

4.  A cell line from pleomorphic adenoma of the rat salivary gland.

Authors:  M Okada; T Seto; K Tsukidate; T Chiba; M Sobue; J Takeuchi
Journal:  Jikken Dobutsu       Date:  1985-01

Review 5.  The World Health Organization's Histological Classification of Salivary Gland Tumors. A commentary on the second edition.

Authors:  G Seifert; L H Sobin
Journal:  Cancer       Date:  1992-07-15       Impact factor: 6.860

6.  Parotid gland papillary cystadenocarcinoma in a Fischer 344 rat.

Authors:  S Hosokawa; T Imai; K Hayakawa; T Fukuta; F Sagami
Journal:  Contemp Top Lab Anim Sci       Date:  2000-05

7.  Immunoreactivity of alpha smooth muscle actin in salivary gland tumours: a comparison with S100 protein.

Authors:  H Jones; F Moshtael; R H Simpson
Journal:  J Clin Pathol       Date:  1992-10       Impact factor: 3.411

8.  p63: a novel myoepithelial cell marker in canine mammary tissues.

Authors:  A Gama; A Alves; F Gartner; F Schmitt
Journal:  Vet Pathol       Date:  2003-07       Impact factor: 2.221

9.  Epithelial-myoepithelial carcinoma of the minor salivary glands: immunohistochemical and morphological features.

Authors:  Francesca Angiero; Davide Sozzi; Rossella Seramondi; Maria Gabriella Valente
Journal:  Anticancer Res       Date:  2009-11       Impact factor: 2.480

10.  Spontaneous Basal cell carcinoma of the submandibular gland in a rat.

Authors:  Yoshihiko Kobayashi; Hiro Eda; Emiko Kajino; Yoshiki Tate; Masami Hiruma; Yasuki Akie; Akemi Saito; Toshihito Kadota
Journal:  J Toxicol Pathol       Date:  2010-10-05       Impact factor: 1.628

View more
  2 in total

1.  Recurrent myoepithelial carcinoma of the submandibular gland treated by rAd-p53 combined with radiotherapy: A case report.

Authors:  Lin Yang; Xiangxun Chen; Hongyan Wang; Qingming Shi
Journal:  Oncol Lett       Date:  2016-06-16       Impact factor: 2.967

2.  Poorly differentiated salivary gland carcinoma with prominent squamous metaplasia in a pregnant Wistar Hannover rat.

Authors:  Yuko Shimada; Toshinori Yoshida; Naofumi Takahashi; Satoshi Akema; Katsumi Soma; Aya Ohnuma-Koyama; Akira Sato; Maki Kuwahara; Takanori Harada
Journal:  J Vet Med Sci       Date:  2016-01-18       Impact factor: 1.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.